Nuvectis Pharma, Inc. (NVCT)
20.55
-1.37
(-6.25%)
USD |
NASDAQ |
Oct 05, 12:21
Nuvectis Pharma Price : 20.55 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 21.11 | 22.00 | 21.04 | 21.92 | 207521.0 |
| Oct 01, 2026 | 21.33 | 21.90 | 20.53 | 20.72 | 168273.0 |
| Sep 30, 2026 | 20.73 | 21.62 | 20.41 | 21.12 | 240278.0 |
| Sep 29, 2026 | 20.91 | 21.40 | 20.11 | 20.53 | 160044.0 |
| Sep 28, 2026 | 20.00 | 21.24 | 19.55 | 20.81 | 137909.0 |
| Sep 25, 2026 | 21.81 | 21.95 | 20.22 | 20.22 | 191813.0 |
| Sep 24, 2026 | 21.38 | 21.99 | 20.65 | 21.63 | 258188.0 |
| Sep 23, 2026 | 23.00 | 23.00 | 20.94 | 21.07 | 169190.0 |
| Sep 22, 2026 | 22.26 | 23.18 | 21.78 | 23.00 | 123965.0 |
| Sep 21, 2026 | 22.02 | 22.39 | 21.40 | 21.98 | 166374.0 |
| Sep 18, 2026 | 21.27 | 23.00 | 21.06 | 22.00 | 880123.0 |
| Sep 17, 2026 | 22.31 | 22.31 | 20.00 | 21.38 | 240932.0 |
| Sep 16, 2026 | 21.84 | 22.41 | 21.31 | 21.87 | 136416.0 |
| Sep 15, 2026 | 23.00 | 23.01 | 21.78 | 21.92 | 166136.0 |
| Sep 14, 2026 | 23.25 | 24.12 | 22.79 | 23.35 | 203430.0 |
| Sep 11, 2026 | 22.96 | 24.24 | 22.28 | 23.99 | 221084.0 |
| Sep 10, 2026 | 22.09 | 23.02 | 22.01 | 22.49 | 107048.0 |
| Sep 09, 2026 | 23.89 | 24.54 | 22.67 | 22.78 | 165627.0 |
| Sep 08, 2026 | 24.00 | 24.69 | 22.73 | 23.99 | 136308.0 |
| Sep 04, 2026 | 24.00 | 25.19 | 23.96 | 24.49 | 117165.0 |
| Sep 03, 2026 | 24.00 | 24.62 | 22.82 | 24.37 | 135967.0 |
| Sep 02, 2026 | 23.06 | 24.01 | 23.06 | 23.92 | 188613.0 |
| Sep 01, 2026 | 22.80 | 23.81 | 22.77 | 23.06 | 176925.0 |
| Aug 31, 2026 | 23.52 | 24.35 | 22.57 | 22.73 | 192565.0 |
| Aug 28, 2026 | 24.93 | 25.65 | 23.29 | 23.73 | 137203.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Opus Genetics, Inc. | 4.47 |
| Faeth Therapeutics, Inc. | 27.23 |
| ACADIA Pharmaceuticals, Inc. | 19.67 |
| Alnylam Pharmaceuticals, Inc. | 216.87 |
| Savara, Inc. | 4.78 |
Price Related Metrics
| PEG Ratio | -1.188 |
| Price to Book Value | 60.40 |
| Earnings Yield | -6.22% |
| Market Cap | 548.58M |
| PEGY Ratio | -1.188 |